Bioaxial

About:

Bioaxial develops new technologies for fluorescence microscopy to improve extended imaging of live cells.

Twitter/X: bioaxial

Top Investors: EASME - EU Executive Agency for SMEs, CEA Investissement, ACG Management, Inserm Transfert Initiative

Description:

Bioaxial develops new technology for super-resolved fluorescence microscopy for extended imaging of live cells with a resolution of less than 100 nanometers. The optical modules manufactured by Bioaxial adapt as an add-on for commercial microscopes. Bioaxial has filed four patents and has acquired a fifth, all of which are held exclusively by the company.

Total Funding Amount:

$6.91M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2010-01-01

Contact Email:

info(AT)bioaxial.com

Founders:

Gabriel Sirat, Louis Braitbart

Number of Employees:

11-50

Last Funding Date:

2018-07-01

IPO Status:

Private

Industries: